The board of Piramal Pharma at its meeting held on 28 January 2026 has approved the following change:Resignation of Tanya Sanish as company secretary and compliance officer with effect from 20 February 2026. Appointment of Pratibha Mishra (ACS No. 53432), as interim company secretary and compliance officer, KMP of the Company with effect from 21 February 2026.Powered by Capital Market - Live News

Net loss of Piramal Pharma reported to Rs 136.19 crore in the quarter ended December 2025 as against net profit of Rs 3.68 crore during the previous quarter ended December 2024. Sales declined 2.92% to Rs 2139.87 crore in the quarter ended December 2025 as against Rs 2204.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2139.872204.22 -3 OPM %9.1515.32 - PBDT159.99263.61 -39 PBT-52.7566.80 PL NP-136.193.68 PL Powered by Capital Market - Live News

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live News

Net loss of Piramal Pharma reported to Rs 99.22 crore in the quarter ended September 2025 as against net profit of Rs 22.59 crore during the previous quarter ended September 2024. Sales declined 8.83% to Rs 2043.72 crore in the quarter ended September 2025 as against Rs 2241.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2043.722241.75 -9 OPM %7.7615.24 - PBDT156.66312.34 -50 PBT-46.18120.12 PL NP-99.2222.59 PL Powered by Capital Market - Live News

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 5 November 2025.Powered by Capital Market - Live News